Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2015 by University of Pittsburgh
Bristol-Myers Squibb
Information provided by (Responsible Party):
University of Pittsburgh Identifier:
First received: November 30, 2011
Last updated: September 24, 2015
Last verified: September 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2017
  Estimated Primary Completion Date: October 2016 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):